Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells

• Egile Nagusiak: Marta Pelon (Egilea), Patryk Krzeminski (Egilea), Zuzanna Tracz-Gaszewska (Egilea), Irena Misiewicz-Krzeminska (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Multiple myeloma is an incurable cancer that originates from antibody-producing plasma cells. It is characterized by an intrinsic ability to produce large amounts of immunoglobulin-like proteins. The high rate of synthesis makes myeloma cells dependent on protein processing mechanisms related to the...